Literature DB >> 30879303

Functional Insights from the Proteomic Inventory of Ovine Forestomach Matrix.

Sandi G Dempsey1, Christopher H Miller1, Ryan C Hill2, Kirk C Hansen2, Barnaby C H May1.   

Abstract

Ovine forestomach matrix (OFM) is a decellularized extracellular matrix (dECM) biomaterial that serves as a scaffold for remodeling damaged soft tissue. dECM biomaterials are used in a variety of clinical applications, and their regenerative capacity is encoded not only in their biophysical properties but also in their molecular diversity. In this study, the proteome of OFM was characterized via both targeted and global mass spectrometry (MS) with the use of heavy isotope labeled (SIL) internal standards. Proteins were identified following either chemical digestion or extraction using saline or guanidine hydrochloride, followed by high resolution size exclusion chromatography. Identified proteins were annotated using the matrisome database and molecular function using the gene ontology database. The characterization identified 153 unique matrisome proteins, including 25 collagens, 58 glycoproteins, 12 proteoglycans, 13 ECM affiliated proteins, 20 ECM regulators, and 23 secreted factors. This inventory represents a comprehensive array of matrix proteins that are retained in OFM after processing. The diversity of proteins identified may contribute to OFM's remodeling capacity in clinical applications.

Entities:  

Keywords:  QconCat; extracellular matrix; mass spectrometry; matrisome; ovine forestomach matrix; proteome

Mesh:

Substances:

Year:  2019        PMID: 30879303     DOI: 10.1021/acs.jproteome.8b00908

Source DB:  PubMed          Journal:  J Proteome Res        ISSN: 1535-3893            Impact factor:   4.466


  7 in total

Review 1.  Proteomics, Glycomics, and Glycoproteomics of Matrisome Molecules.

Authors:  Rekha Raghunathan; Manveen K Sethi; Joshua A Klein; Joseph Zaia
Journal:  Mol Cell Proteomics       Date:  2019-08-30       Impact factor: 5.911

2.  In-Vivo Evaluation of a Reinforced Ovine Biologic for Plastic and Reconstructive Procedures in a Non-human Primate Model of Soft Tissue Repair.

Authors:  Neal Overbeck; Amy Beierschmitt; Barnaby Ch May; Shijie Qi; Jennifer Koch
Journal:  Eplasty       Date:  2022-09-14

3.  Retrospective real-world comparative effectiveness of ovine forestomach matrix and collagen/ORC in the treatment of diabetic foot ulcers.

Authors:  Brandon A Bosque; Christopher Frampton; Abigail E Chaffin; Gregory A Bohn; Kevin Woo; Candace DeLeonardis; Brian D Lepow; M Mark Melin; Tobe Madu; Shane G Dowling; Barnaby C H May
Journal:  Int Wound J       Date:  2021-08-06       Impact factor: 3.099

Review 4.  Sterilization and disinfection methods for decellularized matrix materials: Review, consideration and proposal.

Authors:  Meihan Tao; Tianrang Ao; Xiaoyan Mao; Xinzhu Yan; Rabia Javed; Weijian Hou; Yang Wang; Cong Sun; Shuang Lin; Tianhao Yu; Qiang Ao
Journal:  Bioact Mater       Date:  2021-02-27

5.  In-vivo evaluation of a reinforced ovine biologic: a comparative study to available hernia mesh repair materials.

Authors:  N Overbeck; G M Nagvajara; S Ferzoco; B C H May; A Beierschmitt; S Qi
Journal:  Hernia       Date:  2020-01-31       Impact factor: 4.739

6.  Further structural characterization of ovine forestomach matrix and multi-layered extracellular matrix composites for soft tissue repair.

Authors:  Matthew J Smith; Sandi G Dempsey; Robert Wf Veale; Claudia G Duston-Fursman; Chloe A F Rayner; Chettha Javanapong; Dane Gerneke; Shane G Dowling; Brandon A Bosque; Tanvi Karnik; Michael J Jerram; Arun Nagarajan; Ravinder Rajam; Alister Jowsey; Samuel Cutajar; Isaac Mason; Roderick G Stanley; Andrew Campbell; Jenny Malmstrom; Chris H Miller; Barnaby C H May
Journal:  J Biomater Appl       Date:  2021-11-07       Impact factor: 2.646

7.  Lysosomal cathepsin creates chimeric epitopes for diabetogenic CD4 T cells via transpeptidation.

Authors:  Brendan Reed; Frances Crawford; Ryan C Hill; Niyun Jin; Janice White; S Harsha Krovi; Philippa Marrack; Kirk Hansen; John W Kappler
Journal:  J Exp Med       Date:  2021-02-01       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.